3.96400 EUR
0.17
4.11%
Last update Dec 17, 9:25 PM CET
Main market
Day range
3.83200
3.96400
Previous close
4.13400
Open
3.83200
Access this stock data via API
Subscribe
Arbutus Biopharma Corporation
3.96
0.17
4.11%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 5.3M 18.1M 39.0M 11.0M
Cost of revenue
Gross profit
Operating expense
Research & development 46.1M 73.7M 84.4M 65.5M
Selling general and admin 18.8M 22.5M 17.8M 17.1M
Other operating expenses
Operating income -59.7M -78.0M -63.2M -71.7M
Non operating interest income
Income 5.6M 5.7M 2.2M 127K
Expense 116.8K 459K 1.7M 2.9M
Other income expense -5.5M -44K -2.3M -1.9M
Pretax income -59.6M -72.8M -65.0M -76.2M
Tax provision 0 0 4.4M 0
Net income -59.6M -72.8M -69.5M -76.2M
Basic EPS -0.4 -0.4 -0.5 -0.8
Diluted EPS -0.4 -0.4 -0.5 -0.8
Basic average shares 158.2M 179.1M 155.0M 109.1M
Diluted average shares 158.2M 179.1M 155.0M 109.1M
EBITDA -52.9M -70.9M -59.6M -69.8M
Net income from continuing op. -59.6M -72.8M -69.5M -76.2M
Minority interests
Preferred stock dividends 0 12.1M
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 1 hour 11 minutes

20:48
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).